MK0822
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MK0822, covering 2015-11-02 to 2016-08-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030) [Phase 3]